Skip to main content

Fiscal Wizard · Single-issue tearsheet

CING / Jun 20, 2026 Run #7188

CING

Cingulate Inc.

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Composite verdict

F 18.7 / 100
Bearish setup · Reversal 5 drivers · 5 gates blocking
  • Accumulation/Distribution Line
  • Williams %R
  • Engulfing
Consider long put target Δ ~0.60 · ~35 DTE Bearish setup, Grade B → ITM put target

Industry rank 289th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 17 signals100% Bear
Momentum Bearish 33Mean-reversion Bearish 30

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

26.8 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Return on Capital Employed 0
P/B 75
Greenblatt ROC 0
Free Cash Flow Yield 0

Technicals Bearish

10.6 / 100

Bearish setup leads (Accumulation/Distribution Line, Williams %R, Engulfing); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 8
Williams %R 8
Engulfing 15

Risk Gates

5 blocking 6 caution

5 guards active, 23 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Debt-to-Assets Blocking

High debt-to-assets blocks bullish signals — balance-sheet leverage risk.

Debt-to-Equity Blocking

High debt-to-equity blocks bullish signals — leverage risk.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CING.